Gsk (GSK) Change in Taxes (2009 - 2026)

Gsk (GSK) has 18 years of Change in Taxes data on file, last reported at -$570.6 million in Q3 2026.

• For the quarter ending Q3 2026, Change in Taxes changed N/A year-over-year to -$570.6 million; the trailing twelve-month figure through Sep 2026 stood at -$1.7 billion (changed N/A YoY), and the FY2025 full-year result was -$1.6 billion, up 4.3% from the prior year.
• Change in Taxes was -$570.6 million for Q3 2026 at Gsk, down from -$281.8 million in the prior quarter.
• In the past five years, Change in Taxes ranged from a high of -$195.9 million in Q1 2022 to a low of -$904.9 million in Q4 2024.
• A 5-year average of -$460.8 million and a median of -$427.5 million in 2023 frame the typical range for Change in Taxes.
• Across the five-year window, Change in Taxes sank 45.19% in 2023 and grew 27.53% in 2025, its largest moves.
• Gsk's Change in Taxes stood at -$626.3 million in 2022, then retreated by 8.39% to -$678.9 million in 2023, then tumbled by 33.28% to -$904.9 million in 2024, then advanced by 27.53% to -$655.8 million in 2025, then climbed by 12.98% to -$570.6 million in 2026.
• Per Business Quant data, the three most recent Change in Taxes figures were -$570.6 million in Q3 2026, -$281.8 million in Q1 2026, and -$655.8 million in Q4 2025.